During the last session, ATAI Life Sciences N.V. (NASDAQ:ATAI)’s traded shares were 0.88 million, with the beta value of the company hitting 0.96. At the end of the trading day, the stock’s price was $1.93, reflecting an intraday gain of 4.89% or $0.09. The 52-week high for the ATAI share is $2.85, that puts it down -47.67 from that peak though still a striking 47.15% gain since the share price plummeted to a 52-week low of $1.02. The company’s market capitalization is $323.10M, and the average trade volume was 1.62 million shares over the past three months.
ATAI Life Sciences N.V. (NASDAQ:ATAI) trade information
ATAI Life Sciences N.V. (ATAI) registered a 4.89% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 4.89% in intraday trading to $1.93, hitting a weekly high. The stock’s 5-day price performance is 4.32%, and it has moved by 7.82% in 30 days. Based on these gigs, the overall price performance for the year is 3.21%.
ATAI Life Sciences N.V. (ATAI) estimates and forecasts
Statistics show that ATAI Life Sciences N.V. has underperformed its competitors in share price, compared to the industry in which it operates. ATAI Life Sciences N.V. (ATAI) shares have gone up 62.18% during the last six months, with a year-to-date growth rate less than the industry average at -220.00% against 11.90. In the rating firms’ projections, revenue will decrease -4.50% compared to the previous financial year.
As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 40k and 172k respectively.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 44.19%. While earnings are projected to return -210.00% in 2024.
ATAI Dividends
ATAI Life Sciences N.V. is due to release its next quarterly earnings in May. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
